« Back to Research Deepdives

Omega-3’s Enhance Liver Fat Reduction and Fat Oxidation

This content is restricted to members.

To view our premium content, sign up for a membership:

Register New Account

Username

First Name

Last Name

Password

Password Again

Choose your membership level

Monthly Membership - €24.99 - 1 Month
Full Education Hub access: the weekly Study Deepdive, bi-monthly video Research Lectures, Exclusive Articles, and the full backcatalog of Deepdives in downloadable pdf format.
Annual Membership - €249.99 - 1 Year
Access to all the Education Hub content, at a reduced annual rate.

Discount Code - Valid - Invalid

Choose Your Payment Method

Credit / Debit Card PayPal

I agree to the privacy policy

‹ Back to Research Deepdives

References

1. Yki-Järvinen H. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. The Lancet Diabetes & Endocrinology. 2014;2(11):901-910.
2. Kotronen A, Yki-Järvinen H. Fatty Liver: A Novel Component of the Metabolic Syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28(1):27-38.
3. Summers L, Fielding B, Bradshaw H, Ilic V, Beysen C, Clark M et al. Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia. 2002;45(3):369-377.
4. Park Y, Harris W. Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance. Journal of Lipid Research. 2002;44(3):455-463.
5. Mostad I, Bjerve K, Bjorgaas M, Lydersen S, Grill V. Effects of n−3 fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation. The American Journal of Clinical Nutrition. 2006;84(3):540-550.
6. Umpleby M, Fielding B. Stable Isotopes in Nutrition Research. In: Lovegrove J, Hodson L, Sharma S, Lanham-New S, ed. by. Nutrition Research Methodologies. 1st ed. John Wiley & Sons Ltd; 2015. p. p. 262.